Study of idiopathic inflammatory myopathies with special reference to borderland between idiopathic inflammatory myopathies and muscular dystrophies

Neurology India

Volumn 56, Issue 3, 2008, Pages 356-362

  Khadilkar, Satish ^a,c   Patil, Shekhar ^b   Amin, Sanjeev ^c  

^a SIR J J GROUP OF HOSPITALS   (India)

^b Kokilaben Dhirubhai Ambani Hospital   (India)

^c BOMBAY HOSPITAL   (India)

Author keywords

Inflammatory myopathies; Muscular dystrophy; Scoring system

Indexed keywords

ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; ELECTROPHYSIOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIMB GIRDLE MUSCULAR DYSTROPHY; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MYOSITIS; POLYMYOSITIS; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; BIOPSY; CALCINEURIN; CHILD; CREATINE KINASE; DATA COLLECTION; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; MYOSITIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SARCOGLYCANS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 56049106359     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.43456     Document Type: Article

References (27)

1. Amato AA, Griggs RC. Unicorns, dragons, polymyositis and other mythological beasts. Neurology 2003;61:288-9.
2. Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. Neurol Clin 1997;15:615-48.
3. Khadilkar SV. LGMD in Mumbai region, India. In: Burgress VN, editor. Trends in muscular dystrophy research. 1st ed. USA: Nova Science; 2005. p. 32-59.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis: Part 1. N Engl J Med 1975;292:344-7.
5. Bushby KM. Limb girdle muscular dystrophy. In: Emery AE, editor. Diagnostic criteria for neuromuscular disorders. 3rd ed. The Netherlands: Baarn; 1994. p. 25-31.
6. Khadilkar SV, Singh RK, Kulkarni KS, Chitale AR. A study of clinical and laboratory features of 14 Indian patients with dysferlinopathy. J Clin Neuromusc Dis 2004;6:1-8.
7. Khadilkar SV, Singh RK, Katrak SM. Sarcoglycanopathies: A report of 25 cases. Neurol India 2002;50:27-32.
8. Porkodi R, Shanmuganandan K, Parthiban M, Madhavan R, Rajendran P. Clinical spectrum of inflammatory myositis in South India: A ten year study. J Assoc Physicians India 2002;50:1255-8.
9. Prasad ML, Sarkar C, Roy S, Bagchi U, Singh RR, Singh YN, et al. Idiopathic inflammatory myopathy: Clinico pathological observations in the Indian population. Br J Rheumatol 1992;31:835-9.
10. Thussu A, Prabhakar S, Bansal SK, Sawhney IMS, Chopra JS. Polymyositis: A clinical profile. Neurol India 1993;41:93-7.
11. Gupta SJ. The idiopathic inflammatory myopathies: Current perspectives and management. J Indian Rheumatol Assoc 2004;12:58-9.
12. Lynn SJ, Sawyers SM, Moller PW, O'Donnell JL, Chapman PT. Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001. Intern Med J 2005;35:170-3.
13. Baron M, Small P. Polymyositis/dermatomyositis: Clinical features and outcome in 22 patients. J Rheumatol 1985;12:283-6.
14. Koh ET, Seow A, Ong B, Ratnagopal P, Tjia H, Chng HH. Adult onset polymyositis/dermatomyositis: Clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 1993;52:857-61.
15. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: Epidemiology, classification and diagnostic criteria. Rheum Dis Clin N Am 2002;28:723-42.
16. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: Analysis of 100 French Canadian patients. Medicine 2005;84:231-49.
17. Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, et al. Clinical and serological characteristics of 125 Dutch myositis patients: Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 2002;249:69-75.
18. Ramanan AV, Feldman BM. Clinical features and outcomes of Juvenile Dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin N Am 2002;28:833-58.
19. van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, et al. Polymyositis: An over diagnosed entity. Neurology 2003;61:316-21.
20. Dalakas MC. Progress in inflammatory myopathies: Good but not good enough. J Neurol Neurosurg Psychiatry 2001;70:569-73.
21. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325:1487-98.
22. Pestronk A, Kos K, Lopate G, Al-Lozi MT. Brachio-cervical inflammatory myopathies: Clinical, immune and myopathologic features. Arthritis Rheum 2006;54:1687-96.
23. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet 2001;357:96-100.
24. Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin N Am 2002;28:779-98.
25. Hoffman EP, Rao D, Pachman LM. Clarifying the boundaries between inflammatory and dystrophic myopathies: Insights from molecular diagnostics and microarrays. Rheum Dis Clin N Am 2002;28:743-57.
26. Gallardo E, Rojas-García R , De Luna N, Pou A, Brown RH Jr, Illa I. Inflammation in dysferlin myopathy: Immunohistochemical characterization of 13 patients. Neurology 2001;57:2136-8.
27. Greenberg SA, Sanoudou D, Haslett JN, Kohane IS, Kunkel LM, Beggs AH, et al. Molecular profiles of the inflammatory myopathies. Neurology 2002;59:1170-82.